Brian Weiss
Impact in
Papers in
- Co-authors
- KEVIN M. SHANNON (5 shared papers)Andrew T. Trout (7 shared papers)Gideon E. Bollag (3 shared papers)Michael J. Gelfand (4 shared papers)Susan E. Sharp (2 shared papers)Katherine K. Matthay (6 shared papers)Michael J. Fisher (6 shared papers)Rebecca J. Chan (1 shared paper)
- Journals
- Pediatric Blood & Cancer (13 papers)Neuro-Oncology (8 papers)Journal of Clinical Oncology (5 papers)Clinical Cancer Research (4 papers)Transplantation and Cellular Therapy (3 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Brian Weiss
64 papers receiving 4k citations
Brian Weiss's Hit Papers
Peers
Comparison fields: 5 of 106
- Neurology 1.9k
- Genetics 217
- Surgery 696
- Oncology 253
- Hematology 147
Countries citing papers authored by Brian Weiss
This map shows the geographic impact of Brian Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Weiss more than expected).
Fields of papers citing papers by Brian Weiss
This network shows the impact of papers produced by Brian Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Weiss. The network helps show where Brian Weiss may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Weiss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies Hit paper breakdown → | 2016 | 644 |
| 2 | Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas Hit paper breakdown → | 2016 | 532 |
| 3 | Selumetinib in Children with Inoperable Plexiform Neurofibromas Hit paper breakdown → | 2020 | 507 |
| 4 | Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results Hit paper breakdown → | 2023 | 144 |
| 5 | 2016 | 135 | |
| 6 | 2008 | 117 | |
| 7 | 2014 | 115 | |
| 8 | 1999 | 111 | |
| 9 | 2016 | 102 | |
| 10 | 2022 | 98 | |
| 11 | 2021 | 96 | |
| 12 | 2022 | 84 | |
| 13 | 2015 | 75 | |
| 14 | 2013 | 73 | |
| 15 | 2018 | 72 | |
| 16 | 2014 | 68 | |
| 17 | 2022 | 68 | |
| 18 | 2023 | 68 | |
| 19 | 2003 | 67 | |
| 20 | 2015 | 67 |
About Brian Weiss
Brian Weiss is a scholar working on Neurology, Genetics, Hematology, Emergency Medical Services and Pulmonary and Respiratory Medicine, having authored 68 papers that have together received 4.1k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (26 papers), Neurofibromatosis and Schwannoma Cases (19 papers), Acute Myeloid Leukemia Research (4 papers), Sarcoma Diagnosis and Treatment (4 papers), Glioma Diagnosis and Treatment (3 papers), Multiple and Secondary Primary Cancers (2 papers), Pharmaceutical studies and practices (2 papers) and Patient Safety and Medication Errors (2 papers). The work is most often cited by research in Neurology (1.9k citations), Genetics (217 citations), Surgery (696 citations), Oncology (253 citations) and Hematology (147 citations). Brian Weiss has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include KEVIN M. SHANNON, Andrew T. Trout, Gideon E. Bollag, Michael J. Gelfand, Susan E. Sharp, Katherine K. Matthay, Michael J. Fisher, Rebecca J. Chan, Brigitte Widemann and Mignon L. Loh. Their work appears in journals such as Pediatric Blood & Cancer, Neuro-Oncology, Journal of Clinical Oncology, Clinical Cancer Research and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.